spiralis showed an increasing trend after treatment with low concentration of BafA1, the loss of the auxiliary transport function due to the inhibition of Ts -ATP6V0C activity still led to the inhibition of the worm’s vitality.
← all excerpts
Bafilomycin A1 is a promising therapeutic agent against T. spiralis infection by inhibiting the heme-transporting ATP6V0C/HRG-1 complex.
1
—
—